Press Release
SOURCE: StockDiagnostics.com Inc.
StockDiagnostics.com Downgrades Sears OPS Ranking
NEW YORK, May 28, 2002 (PRIMEZONE) -- Sears' OPS(TM) (Operational-cashflow Per Share) was negative for its most recent quarter ended March 31, 2002. StockDiagnostics.com has downgraded Sears Roebuck & Co. (NYSE:S - news) to an OPS Ranking(TM) of "2." An OPS Ranking of "2" is the second highest that a company can receive. OPS Rankings on more than 7,500 companies can be found at: http://www.stockdiagnostics.com
Sears' OPS Ranking decrease was justified by its recently filed Cash Flow Statements for its first quarter ended March 31, 2002. Its computed OPS (Operational-cashflow Per Share) for the quarter was ($.14) per share as compared to $1.80 per share for the quarter ended March 31, 2001. To view Sears' quarterly OPS Diagnostic chart go to: http://www.stockdiagnostics.com/member/company/20qtrs/13/39513.htm
Sears' OPS for its most recent 12 months ended March 31, 2002 declined 43% to $5.07 per share as compared to $8.83 per share for the 12 months ended March 31, 2001. To view Sears' "5 year history-trailing 12 month" OPS Diagnostic chart go to: http://www.stockdiagnostics.com/member/company/5yrs/13/39513.htm
For information on OPS (Operational-cashflow Per Share) go to: http://www.stockdiagnostics.com/member/ops.htm
How are OPS Rankings determined?
OPS Rankings were discovered from StockDiagnostics.com's in-depth research on Operational Cash Flow. These studies revealed that a company's OPS (Operational-cashflow Per Share) logically falls into a mathematical sequence that ranks it into one of eight distinctive risk categories. Rankings are scaled 1 through 8, with number one (1), being the highest ranking and number eight (8), the lowest. A "Ratings Suspended" status is given for all companies diagnosed with The EPS Syndrome(TM) during the most recent four quarters.
For more information on OPS Rankings go to: http://www.stockdiagnostics.com/member/ops_rating.htm
For information on The EPS Syndrome go to: http://www.stockdiagnostics.com/member/eps_syndrome.htm
About StockDiagnostics.com
StockDiagnostics.com has designed and built a proprietary data refinery that automates the process of collecting, sorting and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement and securities pricing variances or anomalies and to monitor changes in the performance of public companies.
For more information on http://StockDiagnostics.com go to: http://www.stockdiagnostics.com/member/help.htm#a1
Disclaimer:
The information provided by StockDiagnostics.com does not constitute a recommendation by StockDiagnostics.com to buy, sell, hold any security, or to follow any particular trading or investment strategy. Also, the information provided should not be construed as an offer, or a solicitation of an offer, to buy or sell securities. An Investor's best course of action must be based upon individual circumstances. StockDiagnostics.com shall not be liable for any damages or costs of any type arising out of or in any way connected with your use of our services.
Contact:
Martin E. Janis & Company, Inc.
Beverly Jedynak, PR Contact
(312) 943-1100, ext. 12
b.jedynak-janispr@worldnet.att.net